| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $30,914,415 ) (Continued on the next page) |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 000 | 3 | NIH | 8/26/2025 | $42,106 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 000 | 3 | NIH | 8/26/2025 | $42,106 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 000 | 3 | NIH | 8/26/2025 | $497,904 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3HL170034 | Asian American Community Cohort and Engagement Study (ACCESS) | 000 | 3 | NIH | 8/26/2025 | $42,106 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA296705 | Targeting p300/CBP in renal cell carcinoma | 000 | 1 | NIH | 8/26/2025 | $483,395 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UH3CA271230 | Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer | 000 | 4 | NIH | 5/13/2025 | $470,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37CA283552 | Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC) | 000 | 2 | NIH | 8/6/2025 | $649,679 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA283396 | Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms | 000 | 3 | NIH | 7/1/2025 | $707,044 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 11 | NIH | 12/24/2024 | $690,669 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | T32CA278766 | Training Grant in Precision Cancer Control | 000 | 3 | NIH | 8/20/2025 | $281,315 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 001 | 3 | NIH | 8/12/2025 | $69,341 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 000 | 3 | NIH | 12/17/2024 | $624,082 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA282766 | Interrogating MRCK Protein Kinases in Ovarian Cancer | 001 | 2 | NIH | 9/16/2025 | $45,190 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA282766 | Interrogating MRCK Protein Kinases in Ovarian Cancer | 000 | 2 | NIH | 3/4/2025 | $406,720 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA286669 | Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer | 000 | 2 | NIH | 11/14/2024 | $94,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00DK128602 | Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions | 001 | 4 | NIH | 8/4/2025 | $249,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 001 | 4 | NIH | 5/29/2025 | $24,900 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 000 | 4 | NIH | 4/23/2025 | $224,100 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 001 | 3 | NIH | 5/1/2025 | $470,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA288297 | Addressing the Training Gap in Oncology on Sexual Health: Development of the Sexual Health Integrative Fellowship Training (SHIFT) Course for Hematology-Oncology Fellows | 000 | 2 | NIH | 5/13/2025 | $161,299 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA271915 | Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer | 005 | 4 | NIH | 7/10/2025 | $779,894 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA276273 | Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment | 000 | 3 | NIH | 6/3/2025 | $412,500 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA292552 | Pilot Studies of NN-01-195, a New Tumor-Targeted AURKA Inhibitor | 000 | 1 | NIH | 6/23/2025 | $186,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U54CA272686 | Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center | 000 | 4 | NIH | 9/11/2025 | $1,431,641 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 3 | NIH | 1/6/2025 | $683,088 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 001 | 3 | NIH | 6/12/2025 | $75,897 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI171568 | Role of ZBP1 in pathogenesis of Salmonella biofilms | 000 | 3 | NIH | 4/25/2025 | $838,667 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269660 | Pancreatic cancer-associated fibroblasts: function, detection, and regulation | 000 | 4 | NIH | 5/15/2025 | $539,269 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 002 | 4 | NIH | 8/6/2025 | $46,750 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 001 | 4 | NIH | 11/5/2024 | $420,750 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 000 | 4 | NIH | 2/14/2025 | $136,564 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 001 | 4 | NIH | 5/29/2025 | $15,174 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 001 | 4 | NIH | 8/8/2025 | $54,956 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 4 | NIH | 11/21/2024 | $494,601 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA251674 | Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma | 000 | 5 | NIH | 6/13/2025 | $427,763 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA214799 | Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant Cancers | 001 | 7 | NIH | 8/27/2025 | $470,000 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA276888 | Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer | 001 | 3 | NIH | 5/22/2025 | $24,899 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA276888 | Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer | 000 | 3 | NIH | 4/30/2025 | $224,101 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 001 | 5 | NIH | 5/26/2025 | $41,049 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 000 | 5 | NIH | 4/10/2025 | $369,440 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA290043 | Thyroid Hormone Inhibits Medulloblastoma Growth by Inducing Tumor Cell Differentiation | 000 | 1 | NIH | 4/23/2025 | $559,587 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI135025 | Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death | 001 | 9 | NIH | 8/28/2025 | $1,460,069 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P01AI102853 | Molecular Basis for γδ T Lineage Specification | 000 | 11 | NIH | 8/18/2025 | $2,444,294 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 001 | 56 | NIH | 5/8/2025 | $2,784,348 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load | 002 | 3 | NIH | 7/25/2025 | $0 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load | 001 | 3 | NIH | 4/24/2025 | $67,889 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load | 000 | 3 | NIH | 12/13/2024 | $611,002 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U01CA260369 | Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients | 000 | 5 | NIH | 8/8/2025 | $422,144 |
| | 2025 | 2025 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA296696 | Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment | 000 | 1 | NIH | 1/28/2025 | $219,351 |
|
